Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth. [electronic resource]

By:

Ortiz, A

Contributor(s):

Plácida Garrón, M
Rovira, A
Moliz, M
Banderas, M
Crespo, M
Sandiumenge, J
Hernando, L
Caramelo, C

Producer: 19930329Description: 471-3 p. digitalISSN:

0250-8095

Subject(s):

Adolescent
Age Factors
Growth Disorders -- etiology
Growth Hormone -- therapeutic use
Humans
Kidney Failure, Chronic -- complications
Male
Recombinant Proteins
Renal Dialysis

Online resources:

Available from publisher's website

In: American journal of nephrology vol. 12

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Case Reports; Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
by Du, Xiaoliu
2 High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma.
by Yue, Chenglong
3 MicroRNA-485-5p attenuates cell proliferation in glioma by directly targeting paired box 3.
by Wang, Ren
4 FoxR2 promotes glioma proliferation by suppression of the p27 pathway.
by Liu, Xuejiao
5 Smoothened is a poor prognosis factor and a potential therapeutic target in glioma.
by Tu, Yiming
6 Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
by Tu, Yiming
7 CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.
by Liu, Xuejiao
8 S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
by Tu, Yiming
9 Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.
by Liu, Xuejiao

Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth.

APA

Ortiz A., Plácida Garrón M., Rovira A., Moliz M., Banderas M., Crespo M., Sandiumenge J., Hernando L. & Caramelo C. (19930329). Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth. : American journal of nephrology.

Chicago

Ortiz A, Plácida Garrón M, Rovira A, Moliz M, Banderas M, Crespo M, Sandiumenge J, Hernando L and Caramelo C. 19930329. Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth. : American journal of nephrology.

Harvard

Ortiz A., Plácida Garrón M., Rovira A., Moliz M., Banderas M., Crespo M., Sandiumenge J., Hernando L. and Caramelo C. (19930329). Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth. : American journal of nephrology.

MLA

Ortiz A, Plácida Garrón M, Rovira A, Moliz M, Banderas M, Crespo M, Sandiumenge J, Hernando L and Caramelo C. Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth. : American journal of nephrology. 19930329.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC